Clinical Trials List
2024-12-01 - 2027-12-31
Phase II
Recruiting10
ICD-10C33
Malignant neoplasm of trachea
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.0
Malignant neoplasm of trachea
-
-
Trial Applicant
STATPLUS, INC.
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/13
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 柯皓文 無
- 黃振洋 無
- 吳教恩 無
- 枋岳甫 無
- Chih-Hsi Kuo 無
- Ping-Chih Hsu 無
- Cheng-Ta Yang 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 王逸熙 Division of Thoracic Medicine
- Chia-Cheng Tseng 無
- CHIN-CHOU WANG 無
- 黃國棟 無
- 張晃智 無
- 鍾聿修 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- YEN-HAN TSENG 無
- 蕭慈慧 無
- Chi-Lu Chiang 無
- Yuh-Min Chen 無
- 趙恒勝 無
- Hsu-ching Huang 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ying-Ming Tsai Tsai 無
- 李岱晃
- 郭家佑 無
- 李玫萱 無
- Chih-Jen Yang 無
- 莊政皓 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
38 participants
-
Global
238 participants
